Tremfya® ,
Guselkumab
Disease
Ulcerative colitis
,
Crohn's disease
,
Drug Class
Biologics/Biosimilars
Delivery Method
IV
or
Injection
or
Brand name:
Tremfya®
,
Drug name:
Guselkumab
Drug type
Interleukin-23 Antagonist
Recommendations for pregnancy
No human data.
Recommendations for breastfeeding
Insufficient trial data. Monoclonal antibodies may be transported across the placenta.
Most common side effects
Induction: respiratory tract infections. Maintenance: injection site reactions, arthralgia, and upper respiratory tract infections.
Other
Rare side effects include: hypersensitivity reactions (anaphylaxis) and risk of infection. Do not take Tremfya if you have active T.B. Avoid use of live vaccines.
Learn more about
Biologics/Biosimilars